https://news.augustaheadlines.com/story/521994/peraso-inc-nasdaq-prso-deploys-stealth-tech-shipment-for-military-use-tapping-500m-nato-market-more-stocks-inside.html 2025-06-17T10:42:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/521992/who-rules-homecare-clinical-nutrition-market-abbott-danone-fresenius-kabi-nestl-in-fierce-competition-focus-report-store.html 2025-06-17T10:38:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/521991/pd1-and-pdl1-inhibitors-competitor-landscape-pipeline-2025-latest-fda-approvals-clinical-trials-and-emerging-therapies-assessment-by-delveinsight-compass-therapeutics-aurigene-discovery-tech.html 2025-06-17T10:36:07+00:00 daily 1.0 https://news.augustaheadlines.com/story/521990/cardiovascular-devices-market-set-to-grow-fromusd6182billionin2025-tousd7878billion-by2030-driven-by-aienabled-diagnostics-and-minimally-invasive-therapies.html 2025-06-17T10:26:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/521989/power-metallic-tsxv-pnpn-secures-largest-saudi-license-amid-june-2025-gold-surge-material-gains-more-stocks-inside.html 2025-06-17T10:22:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/521988/ktgy-honored-with-5-grand-awards-and-7-awards-of-merit-at-2025-gold-nugget-awards.html 2025-06-17T10:18:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/521987/parkinsons-disease-market-to-show-remarkable-growth-trends-from-2024-to-2034-delveinsight-reports-abbvie-mitsubishi-tanabe-pharma-neuroderm-cerevance-amneal-pharma-pharma-two-b-jazz-pharma.html 2025-06-17T10:04:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/521986/gingivitis-market-set-to-grow-substantially-through-2032-delveinsight-projects-procter-and-gamble-colgate-palmolive-glaxosmithkline-amyndas-pharma-rowpar-pharma.html 2025-06-17T09:48:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/521984/pocket-entertainment-elevates-umesh-bude-to-cto-accelerating-its-vision-as-an-ai-entertainment-leader.html 2025-06-17T09:26:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/521983/periodontal-inflammation-market-expected-to-experience-major-growth-by-2032-according-to-delveinsight-geistlich-pharma-ag-noveome-biotherapeutics-amyndas-pharmaceuticals.html 2025-06-17T09:22:03+00:00 daily 1.0